Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| STAT5A | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 2.39E5 | Evidence |
O
|
||||
| STAT5A | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 1.37E5 | Evidence |
|
||||
| STAT5A | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 1.28E5 | Evidence | |||||
| STAT5A | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 1.18E5 | Evidence | |||||
| STAT5A | KIT | KIT: Mast/stem cell growth factor receptor precursor | 1.11E5 | Evidence |
|
||||
| STAT5A | CRKL | CRKL: Crk-like protein | 9.84E4 | Evidence |
O
|
||||
| STAT5A | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 9.37E4 | Evidence |
O
|
||||
| STAT5A | INSR | INSR: Insulin receptor precursor | 6.35E4 | Evidence |
|
||||
| STAT5A | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 5.72E4 | Evidence |
|
||||
| STAT5A | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 3.37E4 | Evidence | |||||
| STAT5A | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 3.01E4 | Evidence |
|
||||
| STAT5A | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 2.58E4 | Evidence |
|
||||
| STAT5A | CREBBP | CREBBP, CBP: CREB-binding protein | 1.07E4 | Evidence | |||||
| STAT5A | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.02E4 | Evidence |
|
||||
| STAT5A | GRAP | GRAP: GRB2-related adapter protein | 7.29E3 | Evidence | |||||
| STAT5A | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 6.59E3 | Evidence | |||||
| STAT5A | HDAC1 | HDAC1, RPD3L1: Histone deacetylase 1 | 6.01E3 | Evidence | |||||
| STAT5A | STAT3 | 2.89E3 | Evidence |
|
|||||
| STAT5A | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 2.27E3 | Evidence | |||||
| STAT5A | MAP2K3 | N/A | 1.67E3 | Evidence | |||||
| STAT5A | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 1.01E3 | Evidence | |||||
| STAT5A | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 835.0 | Evidence | |||||
| STAT5A | SHC4 | SHC-transforming protein 4 | 591.0 | Evidence | |||||
| STAT5A | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 555.0 | Evidence |
|
||||
| STAT5A | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 497.0 | Evidence |
|
||||
| STAT5A | SYK | SYK: Tyrosine-protein kinase SYK | 497.0 | Evidence |
|
||||
| STAT5A | LYN | LYN: Tyrosine-protein kinase Lyn | 407.0 | Evidence | |||||
| STAT5A | HCK | N/A | 407.0 | Evidence | |||||
| STAT5A | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 407.0 | Evidence | |||||
| STAT5A | JAK1 | 407.0 | Evidence |
O
|
|||||
| STAT5A | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 345.0 | Evidence | |||||
| STAT5A | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 325.0 | Evidence | |||||
| STAT5A | CSK | CSK: Tyrosine-protein kinase CSK | 301.0 | Evidence | |||||
| STAT5A | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 275.0 | Evidence |
|
||||
| STAT5A | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 268.0 | Evidence | |||||
| STAT5A | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 200.0 | Evidence |
|
||||
| STAT5A | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 200.0 | Evidence | |||||
| STAT5A | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 177.0 | Evidence |
|
||||
| STAT5A | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 158.0 | Evidence | |||||
| STAT5A | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 135.0 | Evidence | |||||
| STAT5A | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 135.0 | Evidence | |||||
| STAT5A | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 132.0 | Evidence |
|
||||
| STAT5A | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 132.0 | Evidence | |||||
| STAT5A | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 119.0 | Evidence | |||||
| STAT5A | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 119.0 | Evidence | |||||
| STAT5A | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 107.0 | Evidence | |||||
| STAT5A | BMX | N/A | 107.0 | Evidence |
|
||||
| STAT5A | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| STAT5A | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 105.0 | Evidence | |||||
| STAT5A | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 104.0 | Evidence | |||||
| STAT5A | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 90.80 | Evidence | |||||
| STAT5A | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 90.80 | Evidence | |||||
| STAT5A | DOK1 | DOK1: Docking protein 1 | 85.20 | Evidence | |||||
| STAT5A | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 85.20 | Evidence | |||||
| STAT5A | VAV1 | VAV1, VAV: Proto-oncogene vav | 85.20 | Evidence | |||||
| STAT5A | CD2AP | CD2AP: CD2-associated protein | 85.20 | Evidence | |||||
| STAT5A | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 85.20 | Evidence | |||||
| STAT5A | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 81.20 | Evidence | |||||
| STAT5A | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 79.90 | Evidence | |||||
| STAT5A | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 70.10 | Evidence | |||||
| STAT5A | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 65.30 | Evidence | |||||
| STAT5A | WASPIP | N/A | 62.90 | Evidence | |||||
| STAT5A | PTEN | PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du | 62.90 | Evidence | |||||
| STAT5A | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 62.90 | Evidence | |||||
| STAT5A | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 62.90 | Evidence | |||||
| STAT5A | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 57.70 | Evidence | |||||
| STAT5A | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 51.60 | Evidence | |||||
| STAT5A | LCP1 | LCP1, PLS2: Plastin-2 | 51.60 | Evidence | |||||
| STAT5A | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 51.50 | Evidence | |||||
| STAT5A | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 51.50 | Evidence | |||||
| STAT5A | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 51.50 | Evidence | |||||
| STAT5A | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 51.50 | Evidence | |||||
| STAT5A | MET | MET: Hepatocyte growth factor receptor precursor | 47.20 | Evidence | |||||
| STAT5A | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 46.30 | Evidence | |||||
| STAT5A | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 46.30 | Evidence | |||||
| STAT5A | PPP2CB | PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform | 44.20 | Evidence | |||||
| STAT5A | IRS2 | IRS2: Insulin receptor substrate 2 | 43.60 | Evidence | |||||
| STAT5A | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 43.60 | Evidence | |||||
| STAT5A | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 42.6 | Evidence | |||||
| STAT5A | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 39.10 | Evidence | |||||
| STAT5A | NCK2 | NCK2: Cytoplasmic protein NCK2 | 39.10 | Evidence | |||||
| STAT5A | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 38.10 | Evidence | |||||
| STAT5A | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 38.10 | Evidence | |||||
| STAT5A | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 37.90 | Evidence | |||||
| STAT5A | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 37.90 | Evidence | |||||
| STAT5A | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 37.90 | Evidence | |||||
| STAT5A | CCR5 | CCR5: CCR5 receptor (Fragment) | 37.90 | Evidence |
|
||||
| STAT5A | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 37.80 | Evidence | |||||
| STAT5A | LNK | SH2B3, LNK: SH2B adapter protein 3 | 37.80 | Evidence | |||||
| STAT5A | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 37.80 | Evidence | |||||
| STAT5A | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 34.80 | Evidence | |||||
| STAT5A | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 34.80 | Evidence | |||||
| STAT5A | SOS1 | SOS1: Son of sevenless homolog 1 | 33.90 | Evidence | |||||
| STAT5A | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 33.90 | Evidence | |||||
| STAT5A | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 33.90 | Evidence | |||||
| STAT5A | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 33.90 | Evidence | |||||
| STAT5A | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 33.90 | Evidence | |||||
| STAT5A | ACTN4 | ACTN4: Alpha-actinin-4 | 33.90 | Evidence | |||||
| STAT5A | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 33.90 | Evidence | |||||
| STAT5A | CDK2 | CDK2: Cell division protein kinase 2 | 32.80 | Evidence | |||||
| STAT5A | STYK1 | STYK1, NOK: Tyrosine protein-kinase STYK1 | 32.70 | Evidence | |||||
| STAT5A | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 31.70 | Evidence | |||||
| STAT5A | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 31.20 | Evidence |
O
|
||||
| STAT5A | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 31.20 | Evidence | |||||
| STAT5A | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 31.20 | Evidence | |||||
| STAT5A | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 31.20 | Evidence | |||||
| STAT5A | ETS2 | ETS2: Protein C-ets-2 | 28.70 | Evidence | |||||
| STAT5A | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 28.70 | Evidence | |||||
| STAT5A | H1FX | H1FX: Histone H1x | 28.30 | Evidence | |||||
| STAT5A | GAB1 | GAB1: GRB2-associated-binding protein 1 | 28.20 | Evidence | |||||
| STAT5A | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 28.00 | Evidence | |||||
| STAT5A | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 27.90 | Evidence | |||||
| STAT5A | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 27.90 | Evidence | |||||
| STAT5A | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 26.80 | Evidence | |||||
| STAT5A | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 26.40 | Evidence | |||||
| STAT5A | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 26.40 | Evidence | |||||
| STAT5A | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 26.00 | Evidence | |||||
| STAT5A | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 26.00 | Evidence | |||||
| STAT5A | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 26.00 | Evidence |
|
||||
| STAT5A | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 25.70 | Evidence |
|
||||
| STAT5A | BRD2 | BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 | 25.30 | Evidence | |||||
| STAT5A | SAFB | SAFB, HAP, HET, SAFB1: Scaffold attachment factor B | 25.30 | Evidence | |||||
| STAT5A | APS | SH2B2, APS: SH2B adapter protein 2 | 25.3 | Evidence | |||||
| STAT5A | STAM2 | STAM2: Signal transducing adapter molecule 2 | 25.3 | Evidence | |||||
| STAT5A | DAB1 | DAB1: Disabled homolog 1 | 25.3 | Evidence | |||||
| STAT5A | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 25.3 | Evidence | |||||
| STAT5A | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 24.90 | Evidence | |||||
| STAT5A | MDGA1 | MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein | 24.90 | Evidence | |||||
| STAT5A | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 24.90 | Evidence | |||||
| STAT5A | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 24.90 | Evidence | |||||
| STAT5A | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 24.90 | Evidence |
|
||||
| STAT5A | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 24.90 | Evidence | |||||
| STAT5A | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 24.90 | Evidence | |||||
| STAT5A | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 24.90 | Evidence | |||||
| STAT5A | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 24.80 | Evidence | |||||
| STAT5A | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 23.70 | Evidence | |||||
| STAT5A | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 23.70 | Evidence | |||||
| STAT5A | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 23.70 | Evidence | |||||
| STAT5A | GHR | GHR: Growth hormone receptor precursor | 22.90 | Evidence |
|
||||
| STAT5A | EPOR | EPOR: Erythropoietin receptor precursor | 22.90 | Evidence |
|
||||
| STAT5A | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 22.90 | Evidence | |||||
| STAT5A | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 22.90 | Evidence | |||||
| STAT5A | AMPH | AMPH, AMPH1: Amphiphysin | 22.90 | Evidence | |||||
| STAT5A | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 22.80 | Evidence | |||||
| STAT5A | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 22.60 | Evidence | |||||
| STAT5A | IRS1 | IRS1: Insulin receptor substrate 1 | 22.40 | Evidence | |||||
| STAT5A | L1CAM | L1CAM, CAML1, MIC5: Neural cell adhesion molecule L1 precursor | 22.30 | Evidence | |||||
| STAT5A | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 22.30 | Evidence | |||||
| STAT5A | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 22.20 | Evidence | |||||
| STAT5A | DYRK3 | N/A | 22.20 | Evidence | |||||
| STAT5A | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 22.20 | Evidence | |||||
| STAT5A | TRADD | TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein | 21.40 | Evidence | |||||
| STAT5A | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 20.6 | Evidence | |||||
| STAT5A | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 20.6 | Evidence | |||||
| STAT5A | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 20.50 | Evidence | |||||
| STAT5A | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 20.50 | Evidence | |||||
| STAT5A | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 20.50 | Evidence | |||||
| STAT5A | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 20.50 | Evidence | |||||
| STAT5A | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 20.50 | Evidence | |||||
| STAT5A | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
| STAT5A | BIN1 | BIN1, AMPHL: Myc box-dependent-interacting protein 1 | 20.50 | Evidence | |||||
| STAT5A | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 20.50 | Evidence | |||||
| STAT5A | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 20.10 | Evidence | |||||
| STAT5A | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 20.00 | Evidence | |||||
| STAT5A | MYO3A | MYO3A: Myosin IIIA | 20.00 | Evidence | |||||
| STAT5A | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 19.20 | Evidence | |||||
| STAT5A | NMI | NMI: N-myc-interactor | 19.00 | Evidence |
O
|
||||
| STAT5A | CDK5 | CDK5: Cell division protein kinase 5 | 18.90 | Evidence | |||||
| STAT5A | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 18.60 | Evidence | |||||
| STAT5A | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 18.60 | Evidence | |||||
| STAT5A | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 18.60 | Evidence | |||||
| STAT5A | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 18.60 | Evidence |
O
|
||||
| STAT5A | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 18.40 | Evidence | |||||
| STAT5A | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 17.60 | Evidence | |||||
| STAT5A | CDC2 | CDC2: Cell division control protein 2 homolog | 17.60 | Evidence | |||||
| STAT5A | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 17.50 | Evidence | |||||
| STAT5A | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 17.40 | Evidence | |||||
| STAT5A | LOC389305 | Uncharacterized protein ENSP00000349185 (Fragment) | 17.40 | Evidence | |||||
| STAT5A | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 17.10 | Evidence | |||||
| STAT5A | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 16.40 | Evidence | |||||
| STAT5A | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 16.40 | Evidence | |||||
| STAT5A | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 16.30 | Evidence | |||||
| STAT5A | BARD1 | BARD1: BRCA1-associated RING domain protein 1 | 15.30 | Evidence | |||||
| STAT5A | HDAC3 | HDAC3: Histone deacetylase 3 | 15.30 | Evidence | |||||
| STAT5A | CTDP1 | CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase | 15.30 | Evidence | |||||
| STAT5A | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 15.10 | Evidence | |||||
| STAT5A | VCAM1 | VCAM1, L1CAM: Vascular cell adhesion protein 1 precursor | 15.10 | Evidence | |||||
| STAT5A | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 15.10 | Evidence | |||||
| STAT5A | PRLR | PRLR: Prolactin receptor precursor | 14.70 | Evidence | |||||
| STAT5A | ALCAM | ALCAM, MEMD: CD166 antigen precursor | 14.70 | Evidence | |||||
| STAT5A | PTPRJ | PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor | 14.70 | Evidence | |||||
| STAT5A | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 14.60 | Evidence |
|
||||
| STAT5A | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 14.40 | Evidence | |||||
| STAT5A | RPS3 | RPS3, OK/SW-cl.26: 40S ribosomal protein S3 | 14.40 | Evidence | |||||
| STAT5A | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 14.10 | Evidence | |||||
| STAT5A | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 13.90 | Evidence | |||||
| STAT5A | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 13.80 | Evidence | |||||
| STAT5A | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 13.70 | Evidence | |||||
| STAT5A | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 13.70 | Evidence | |||||
| STAT5A | CAMK2D | CAMK2D, CAMKD: Calcium/calmodulin-dependent protein kinase type II delta chain | 13.70 | Evidence | |||||
| STAT5A | PHC2 | PHC2, EDR2, PH2: Polyhomeotic-like protein 2 | 13.50 | Evidence | |||||
| STAT5A | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 13.50 | Evidence | |||||
| STAT5A | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 13.50 | Evidence | |||||
| STAT5A | DAB2 | DAB2, DOC2: Disabled homolog 2 | 13.50 | Evidence | |||||
| STAT5A | SORBS3 | SORBS3, SCAM1: Vinexin | 13.50 | Evidence | |||||
| STAT5A | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 13.40 | Evidence | |||||
| STAT5A | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 13.20 | Evidence | |||||
| STAT5A | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 13.00 | Evidence | |||||
| STAT5A | MCM3 | MCM3: DNA replication licensing factor MCM3 | 12.50 | Evidence | |||||